연구성과로 돌아가기
2025 연구성과별 연구자 정보 (1136 / 1187)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Yang, C. H. | Yang, CH | 11 | Daegu Catholic Univ, Chilgok Catholic Hosp, Internal Med, Daegu, South Korea | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Sagami, S. | Sagami, S | 12 | Univ Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment Kitasato, Tokyo, Japan | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Kobayashi, T. | Kobayashi, T | 13 | Univ Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment Kitasato, Tokyo, Japan | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Mak, J. | Mak, J | 14 | Chinese Univ Hong Kong, Gastroenterol, Hong Kong, Peoples R China | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Liu, J. | Liu, J | 15 | Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Ctr Inflammatory Bowel Dis,Gastroenterol, Hangzhou, Peoples R China | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Cao, Q. | Cao, Q | 16 | Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Ctr Inflammatory Bowel Dis,Gastroenterol, Hangzhou, Peoples R China | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Lin, C. C. | Lin, CC | 17 | Taipei Vet Gen Hosp, Gastroenterol, Taipei, Taiwan | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Lin, W. C. | Lin, WC | 18 | Mackay Mem Hosp, Gastroenterol, Taipei, Taiwan | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Hsu, W. G. | Hsu, WG | 19 | Kaohsiung Med Univ, Gastroenterol, Kaohsiung, Taiwan | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Wei, S. C. | Wei, SC | 20 | Natl Taiwan Univ, Natl Taiwan Univ Hosp, Internal Med, Taipei, Taiwan | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Rice, K. | Rice, K | 21 | Mater Hosp, Gastroenterol, Brisbane, Australia | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | An, Y. K. | An, YK | 22 | Mater Hosp, Gastroenterol, Brisbane, Australia | AAV-2664-2020 | An, Yoon-Kyo | ||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Begun, J. | Begun, J | 23 | Mater Hosp, Gastroenterol, Brisbane, Australia | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Ruddick-Collins, L. | Ruddick-Collins, L | 24 | Univ Queensland, Mater Res Inst, Gastroenterol, Brisbane, Australia | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Fernandes, R. G. | Fernandes, RG | 25 | Mater Hosp, Gastroenterol, Brisbane, Australia | IYT-0155-2023 | Fernandes, Richard |
페이지 이동: